GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (XSWX:BION) » Definitions » Ending Cash Position

BB Biotech AG (XSWX:BION) Ending Cash Position : CHF2.2 Mil (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is BB Biotech AG Ending Cash Position?

BB Biotech AG's Ending Cash Position for the quarter that ended in Sep. 2024 was CHF2.2 Mil.

BB Biotech AG's quarterly Ending Cash Position declined from Mar. 2024 (CHF0.4 Mil) to Jun. 2024 (CHF0.3 Mil) but then increased from Jun. 2024 (CHF0.3 Mil) to Sep. 2024 (CHF2.2 Mil).

BB Biotech AG's annual Ending Cash Position declined from Dec. 2021 (CHF2.8 Mil) to Dec. 2022 (CHF1.9 Mil) and declined from Dec. 2022 (CHF1.9 Mil) to Dec. 2023 (CHF0.5 Mil).


BB Biotech AG Ending Cash Position Historical Data

The historical data trend for BB Biotech AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Ending Cash Position Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.71 6.82 2.84 1.95 0.50

BB Biotech AG Quarterly Data
Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.50 0.41 0.32 2.25

BB Biotech AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BB Biotech AG's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.948+-1.447
=0.5

BB Biotech AG's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.317+1.929
=2.2


BB Biotech AG Ending Cash Position Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG Business Description

Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system.
Executives
Dr. Thomas Von Planta Supervisory Board
Prof. Dr. Mads Krogsgaard Thomsen Supervisory Board

BB Biotech AG Headlines

No Headlines